# Euglycemic Diabetic Ketoacidosis Presenting as Hypoglycemia in a Patient With Type 2 Diabetes and Von Gierke’s Disease

**Authors:** Emmanuel Tito, Akshaya Ramaswami, Ron Milbocker, Darwin Edmond

PMC · DOI: 10.7759/cureus.52104 · Cureus · 2024-01-11

## TL;DR

A patient with Von Gierke’s disease and type 2 diabetes presented with hypoglycemia during diabetic ketoacidosis, requiring glucose-containing fluids before insulin treatment.

## Contribution

This case highlights a rare presentation of DKA with hypoglycemia in a patient with Von Gierke’s disease and type 2 diabetes.

## Key findings

- The patient required glucose-containing fluids before insulin for DKA treatment.
- This case demonstrates hypoglycemia in the context of DKA in a patient with Von Gierke’s disease.
- Use of empagliflozin may have contributed to the hypoglycemic presentation.

## Abstract

Von Gierke’s disease (VGD) is rarely associated with type 2 diabetes mellitus (DM2). We present a case of VGD with DM2 that presented with hypoglycemia in the setting of diabetic ketoacidosis (DKA) in a young male with VGD using the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin. The patient required resuscitation with fluids containing glucose prior to the administration of insulin for DKA protocol with significant clinical improvement. This case demonstrates a rare presentation of DKA with hypoglycemia.

## Linked entities

- **Chemicals:** empagliflozin (PubChem CID 11949646)
- **Diseases:** Von Gierke’s disease (MONDO:0002413), type 2 diabetes mellitus (MONDO:0005148), diabetic ketoacidosis (MONDO:0012819), hypoglycemia (MONDO:0004946)

## Full-text entities

- **Genes:** SLC5A2 (solute carrier family 5 member 2) [NCBI Gene 6524] {aka SGLT2}
- **Diseases:** Type 2 Diabetes (MESH:D003924), DKA (MESH:D016883), Hypoglycemia (MESH:D007003), VGD (MESH:D005953), DM2 (MESH:D009223)
- **Chemicals:** empagliflozin (MESH:C570240), insulin (MESH:D007328), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10858729/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10858729/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC10858729/full.md

---
Source: https://tomesphere.com/paper/PMC10858729